Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹13,655 Cr
Revenue (TTM)
₹3,389 Cr
Net Profit (TTM)
₹207 Cr
ROE
6.3 %
ROCE
6.4 %
P/E Ratio
65.9
P/B Ratio
2.4
Industry P/E
37.78
EV/EBITDA
38
Div. Yield
0.3 %
Debt to Equity
0
Book Value
₹178.1
EPS
₹45.5
Face value
2
Shares outstanding
318,160,720
CFO
₹1,886.18 Cr
EBITDA
₹2,532.57 Cr
Net Profit
₹2,017.79 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zydus Wellness
| -5.6 | 5.9 | 0.6 | 33.4 | 13.4 | 2.8 | 11.7 |
|
BSE FMCG
| -12.4 | -7.1 | -11.8 | -5.9 | 3.0 | 7.6 | 8.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Zydus Wellness
| 15.0 | 17.3 | 11.6 | -20.0 | -8.6 | 35.8 | 7.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
429.4 | 13,655.5 | 3,389.4 | 207.1 | 9.5 | 4.4 | 65.9 | 2.4 |
| 352.9 | 4,605.6 | 1,088.6 | 156.8 | 15.0 | 22.6 | 29.2 | 6.7 | |
| 416.9 | 18,202.1 | 3,817.5 | 798.5 | 21.4 | 28.6 | 22.9 | 5.6 | |
| 0.3 | 67.9 | 450.5 | -67.3 | -8.8 | -- | -- | -0.2 | |
| 214.2 | 7,856.6 | 2,892.8 | 342.7 | 14.0 | 24.5 | 22.9 | 5.2 | |
| 289.5 | 438.6 | 221.4 | -75.4 | -23.1 | -- | -- | -3.3 | |
| 47.9 | 92.7 | 308.8 | 3.9 | 1.5 | 10.9 | 24.2 | 2.4 | |
| 48.1 | 117.2 | 392.0 | -4.7 | 0.9 | -2.7 | -- | 0.7 | |
| 29.8 | 18.0 | 307.8 | 1.8 | 2.0 | 3.3 | 10.1 | 0.4 | |
| 0.5 | 49.8 | 45.6 | -1.1 | -4.5 | -1.1 | -- | 0.5 |
3 min read•By Vikas Vardhan
1 min read•By Vikas Vardhan
1 min read•By Research Desk
4 min read•By Research Desk
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in India, the Middle East, Asia, Africa, the Oceania, and internationally. It provides sugar substitute products under the... Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon-D brand; and I'm lite a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and leave-on-products under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. It also exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Zydus Lifesciences Limited. Read more
Incorporated
1994
Chairman
Sharvil P Patel
Managing Director
--
Group
Cadila
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Zydus Wellness Ltd is ₹429.35 (NSE) and ₹429.20 (BSE) as of 18-Mar-2026 IST. Zydus Wellness Ltd has given a return of 13.39% in the last 3 years.
The P/E ratio of Zydus Wellness Ltd is 65.94 times as on 18-Mar-2026, a 75 premium to its peers’ median range of 37.78 times.
The P/B ratio of Zydus Wellness Ltd is 2.41 times as on 18-Mar-2026, a 65 discount to its peers’ median range of 6.97 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
30.65
|
1.87
|
|
2024
|
35.05
|
1.75
|
|
2023
|
31.76
|
1.92
|
|
2022
|
30.92
|
1.97
|
|
2021
|
105.73
|
2.75
|
The 52-week high and low of Zydus Wellness Ltd are Rs 530.90 and Rs 319.27 as of 19-Mar-2026.
Zydus Wellness Ltd has a market capitalisation of ₹ 13,655 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Zydus Wellness Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹7.35
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.